Cost-Effectiveness Analysis on the Use of Recombinant Human Erythropoietin among Hemodialysis Patients
碩士 === 義守大學 === 管理研究所碩士班 === 96 === Anemia is one of the common problems among patients with chronic kidney disease, and one of the important parameters of dialysis quality measurement. Artificially synthesized erythropoietin (Recombinant human Erythropoietin, rHuEPO) can treat the renal anemia effe...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/27678305470264885195 |